View Item 

Show simple item record

Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three‐Year Follow‐Up
dc.contributor.authorSarwal, M. M.en_US
dc.contributor.authorEttenger, R. B.en_US
dc.contributor.authorDharnidharka, V.en_US
dc.contributor.authorBenfield, M.en_US
dc.contributor.authorMathias, R.en_US
dc.contributor.authorPortale, A.en_US
dc.contributor.authorMcDonald, R.en_US
dc.contributor.authorHarmon, W.en_US
dc.contributor.authorKershaw, D.en_US
dc.contributor.authorVehaskari, V. M.en_US
dc.contributor.authorKamil, E.en_US
dc.contributor.authorBaluarte, H. J.en_US
dc.contributor.authorWarady, B.en_US
dc.contributor.authorTang, L.en_US
dc.contributor.authorLiu, J.en_US
dc.contributor.authorLi, L.en_US
dc.contributor.authorNaesens, M.en_US
dc.contributor.authorSigdel, T.en_US
dc.contributor.authorWaskerwitz, Janieen_US
dc.contributor.authorSalvatierra, O.en_US
dc.date.accessioned2012-10-02T17:20:18Z
dc.date.available2013-11-04T19:53:16Zen_US
dc.date.issued2012-10en_US
dc.identifier.citationSarwal, M. M.; Ettenger, R. B.; Dharnidharka, V.; Benfield, M.; Mathias, R.; Portale, A.; McDonald, R.; Harmon, W.; Kershaw, D.; Vehaskari, V. M.; Kamil, E.; Baluarte, H. J.; Warady, B.; Tang, L.; Liu, J.; Li, L.; Naesens, M.; Sigdel, T.; Waskerwitz, Janie; Salvatierra, O. (2012). "Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three‐Year Follow‐Up." American Journal of Transplantation 12(10). <http://hdl.handle.net/2027.42/93729>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/93729
dc.publisherBlackwell Publishing Incen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherGrowthen_US
dc.subject.otherCorticosteroidsen_US
dc.subject.otherGraft Functionen_US
dc.subject.otherSide Effectsen_US
dc.subject.otherPediatricen_US
dc.subject.otherKidney Transplantationen_US
dc.titleComplete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three‐Year Follow‐Upen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumC.S Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherUniversity Hospitals Leuven, Belgium, EUen_US
dc.contributor.affiliationotherCalifornia Pacific Medical Center, Sutter Health Care, San Francisco, CA, USAen_US
dc.contributor.affiliationotherStanford University Medical School, Stanford, CA, USAen_US
dc.contributor.affiliationotherMattel Children's Hospital, UCLA, Los Angeles, CA, USAen_US
dc.contributor.affiliationotherShands Children's Hospital, University of Florida, Gainsville, FL, USAen_US
dc.contributor.affiliationotherUniversity of Alabama, Birmingham, AL, USAen_US
dc.contributor.affiliationotherUCSF Medical Center, San Francisco, CA, USAen_US
dc.contributor.affiliationotherSeattle Children's Hospital, Seattle, WA, USAen_US
dc.contributor.affiliationotherChildren's Hospital Boston, Boston, MA, USAen_US
dc.contributor.affiliationotherChildren's Hospital New Orleans, New Orleans, LA, USAen_US
dc.contributor.affiliationotherMaxine Dunitz Children's Health Center, Cedars‐Sinai Medical Center, Los Angeles, CA, USAen_US
dc.contributor.affiliationotherThe Children's Hospital of Philadelphia, Philadelphia, PA, USAen_US
dc.contributor.affiliationotherChildren's Mercy Hospital in Kansas City, Missouri, MO, USAen_US
dc.contributor.affiliationotherPharmaceutical Product Development (PPD)en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/93729/1/j.1600-6143.2012.04145.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2012.04145.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceSasaki H, Chikaraishi T, Furuhata S, et al. Anaphylactic reaction after initial exposure of Basiliximab: Case reports. Transplant Proc 2007; 39: 3457 – 3459.en_US
dc.identifier.citedreferenceSilverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM. Results of one‐year follow‐up of steroid‐free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 2005; 9: 589 – 597.en_US
dc.identifier.citedreferenceWouters KM, Lane MH, Walker I. Acute hypersensitivity reaction on re‐exposure to basiliximab in an infant undergoing heart transplantation. Paediatr Anaesth 2008; 18: 806 – 807.en_US
dc.identifier.citedreferenceNaesens M, Kambham N, Salvatierra O, et al. Steroid avoidance in pediatric kidney recipients does not influence subclinical inflammation or chronic renal allograft injury. Am J Transplant 2012; 12: 2730 – 2743.en_US
dc.identifier.citedreferenceWoodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van VP. A prospective, randomized, double‐blind, placebo‐controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long‐term, low‐dose corticosteroid therapy. Ann Surg 2008; 248: 564 – 577.en_US
dc.identifier.citedreferenceGoodwin WE, Mims MM, Kaufman JJ. Human renal transplantation. III. Technical problems encountered in six cases of kidney homotransplantation. J Urol 1963; 89: 349 – 356.en_US
dc.identifier.citedreferenceFine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end‐stage renal disease? Pediatr Nephrol 2010; 25: 739 – 746.en_US
dc.identifier.citedreferenceTravis LB, Chesney R, McEnery P, et al. Growth and glucocorticoids in children with kidney disease. Kidney Int 1978; 14: 365 – 368.en_US
dc.identifier.citedreferenceLi L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein‐Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11: 187 – 195.en_US
dc.identifier.citedreferenceKnight SR, Morris PJ. Azathioprine and steroids. In: Morris P., Knechtle S., eds. Kidney transplantation: Principles and practice. 6e edn. Philadelphia: W.B. Saunders; 2008. pp. 220 – 233.en_US
dc.identifier.citedreferenceStratta RJ, Armbrust MJ, Oh CS, et al. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988; 45: 323 – 328.en_US
dc.identifier.citedreferenceSrinivas TR, Meier‐Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008; 3: S101 – S116.en_US
dc.identifier.citedreferenceBerki T, Tavakoli A, Nagy KK, Nagy G, Nemeth P. Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Transpl Int 2002; 15: 132 – 138.en_US
dc.identifier.citedreferenceWiegers GJ, Labeur MS, Stec IE, Klinkert WE, Holsboer F, Reul JM. Glucocorticoids accelerate anti‐T cell receptor‐induced T cell growth. J Immunol 1995; 155: 1893 – 1902.en_US
dc.identifier.citedreferenceSarwal MM, Rianthavorn P, Ettenger R. Kidney transplantation in children. In: Morris P., Knechtle S., eds. Kidney transplantation: Principles and practice. 6e edn. Philadelphia: W.B. Saunders, 2008, pp. 599 – 629.en_US
dc.identifier.citedreferenceAlmawi WY, Hess DA, Assi JW, Chudzik DM, Rieder MJ. Pretreatment with glucocorticoids enhances T cell effector function: Possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999; 8: 637 – 647.en_US
dc.identifier.citedreferenceAhsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil—a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 1865 – 1874.en_US
dc.identifier.citedreferenceSchwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106: 522 – 526.en_US
dc.identifier.citedreferenceSchwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259 – 263.en_US
dc.identifier.citedreferenceSolez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753 – 760.en_US
dc.identifier.citedreferenceRacusen L, Solez K, Colvin R, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713 – 723.en_US
dc.identifier.citedreferenceBhakta N, Marik J, Malekzadeh M, Gjertson D, Ettenger R. Can pediatric steroid‐free renal transplantation improve growth and metabolic complications? Pediatr Transplant 2008; 12: 854 – 861.en_US
dc.identifier.citedreferenceLi L, Chang A, Naesens M, et al. Steroid‐Free immunosuppression since 1999: 129 Pediatric Renal Transplants with Sustained Graft and Patient Benefits. Am J Transplant 2009; 9: 1362 – 1372.en_US
dc.identifier.citedreferenceSarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13 – 21.en_US
dc.identifier.citedreferenceBenfield MR, Bartosh S, Ikle D, et al. A randomized double‐blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant 2010; 10: 81 – 88.en_US
dc.identifier.citedreferenceGrenda R, Webb NJ. Steroid minimization in pediatric renal transplantation: Early withdrawal or avoidance? Pediatr Transplant 2010; 14: 961 – 967.en_US
dc.identifier.citedreferenceHocker B, Weber LT, Feneberg R, et al. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil. Transplantation 2009; 87: 934 – 941.en_US
dc.identifier.citedreferenceKDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9: S1 – S155.en_US
dc.identifier.citedreferenceSprangers B, Vanrenterghem Y. Steroid avoidance or withdrawal after kidney transplantation: A balancing act. Transplantation 2010; 90: 350 – 352.en_US
dc.identifier.citedreferenceKnight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta‐analysis. Transplantation 2010; 89: 1 – 14.en_US
dc.identifier.citedreferencePascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009; 1: Art. No.: CD005632. DOI: 10.1002/14651858.CD005632.pub2.en_US
dc.identifier.citedreferenceHocker B, John U, Plank C, et al. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years. Transplantation 2004; 78: 228 – 234.en_US
dc.identifier.citedreferenceOpelz G, Dohler B, Laux G. Long‐term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005; 5: 720 – 728.en_US
dc.identifier.citedreferenceVincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008; 8: 307 – 316.en_US
dc.identifier.citedreferenceRostaing L, Cantarovich D, Mourad G, et al. Corticosteroid‐free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 79: 807 – 814.en_US
dc.identifier.citedreferenceVitko S, Klinger M, Salmela K, et al. Two corticosteroid‐free regimens‐tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil‐in comparison with a standard triple regimen in renal transplantation: Results of the Atlas study. Transplantation 2005; 80: 1734 – 1741.en_US
dc.identifier.citedreferenceGrenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant 2010; 10: 828 – 836.en_US
dc.identifier.citedreferenceSarwal M, Benfield M, Ettenger R, et al. One year results of a prospective, randomized, multicenter trial of steroid avoidance in pediatric renal transplantation. Am J Transplant 2008; 8: 192.en_US
dc.identifier.citedreferenceHorslen S, Barr ML, Christensen LL, Ettenger R, Magee JC. Pediatric transplantation in the United States, 1996–2005. Am J Transplant 2007; 7: 1339 – 1358.en_US
dc.identifier.citedreferenceKainz A, Wilflingseder J, Mitterbauer C, et al. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: A randomized, controlled trial. Ann Intern Med 2010; 153: 222 – 230.en_US
dc.identifier.citedreferenceMartins PN, Chandraker A, Tullius SG. Modifying graft immunogenicity and immune response prior to transplantation: Potential clinical applications of donor and graft treatment. Transpl Int 2006 May; 19: 351 – 359.en_US
dc.identifier.citedreferenceBeimler J, Zeier M. Borderline rejection after renal transplantation—to treat or not to treat. Clin Transplant 2009; 23: 19 – 25.en_US
dc.identifier.citedreferenceAlmawi WY, Hess DA, Rieder MJ. Significance of enhanced cytokine receptor expression by glucocorticoids. Blood 1998; 92: 3979 – 3980.en_US
dc.identifier.citedreferenceYang Y, Mercep M, Ware CF, Ashwell JD. Fas and activation‐induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 1995; 181: 1673 – 1682.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2012.04145.x.pdf
Size:
780.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.